Search
CELLCEPT 250 MG, Capsule
Details
| --- | Description |
|---|---|
| Pack | Boîte de 100 |
| Strength (Dosage) | 250 MG |
| Laboratory | ROCHE S.A |
| Ingredients | Mofétil mycophénolate |
| Therapeutic class | Immunosuppresseur sélectif |
| ATC code | L04AA06 |
| PPH | $65.00 |
| PPV | $93.10 |
| Refundable | Yes |
| Refund base | $64.90 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | CellCept est indiqué en association avec des corticoïdes et la ciclosporine pour la prévention des réactions de rejet aiguës chez les patients bénéficiant d'une allogreffe de rein, de cœur ou de foie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem